Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results
Go back to Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results| (NYSE: CLDI) | Delayed: 1.27 -0.09 (6.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.36 | 52 Week High | $ | |||
| Open | $1.32 | 52 Week Low | $ | |||
| Day High | $1.34 | P/E | N/A | |||
| Day Low | $1.25 | EPS | $ | |||
| Volume | 135,777 | |||||

